BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37929990)

  • 1. Hepatitis B doubly spliced protein (HBDSP) promotes hepatocellular carcinoma cell apoptosis via ETS1/GATA2/YY1-mediated p53 transcription.
    Xu X; Zhang L; Ye G; Shi J; Peng Y; Xin F; Lin Y; Wu Q; Lin X; Chen W
    J Virol; 2023 Nov; 97(11):e0108723. PubMed ID: 37929990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B doubly spliced protein, generated by a 2.2 kb doubly spliced hepatitis B virus RNA, is a pleiotropic activator protein mediating its effects via activator protein-1- and CCAAT/enhancer-binding protein-binding sites.
    Chen WN; Chen JY; Lin WS; Lin JY; Lin X
    J Gen Virol; 2010 Oct; 91(Pt 10):2592-600. PubMed ID: 20538904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():144-52. PubMed ID: 21199526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B x antigen and p53 in the development of hepatocellular carcinoma.
    Feitelson MA
    J Hepatobiliary Pancreat Surg; 1998; 5(4):367-74. PubMed ID: 9931385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
    Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
    Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DTNA promotes HBV-induced hepatocellular carcinoma progression by activating STAT3 and regulating TGFβ1 and P53 signaling.
    Hu ZG; Zhang S; Chen YB; Cao W; Zhou ZY; Zhang JN; Gao G; He SQ
    Life Sci; 2020 Oct; 258():118029. PubMed ID: 32619495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doubly Spliced RNA of Hepatitis B Virus Suppresses Viral Transcription via TATA-Binding Protein and Induces Stress Granule Assembly.
    Tsai KN; Chong CL; Chou YC; Huang CC; Wang YL; Wang SW; Chen ML; Chen CH; Chang C
    J Virol; 2015 Nov; 89(22):11406-19. PubMed ID: 26339052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells.
    Qu J; Lin J; Zhang S; Zhu Z; Ni C; Zhang S; Gao H; Zhu M
    Biochem Biophys Res Commun; 2009 Aug; 386(3):504-9. PubMed ID: 19540192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mutant 10Ala/Arg together with mutant 144Ser/Arg of hepatitis B virus X protein involved in hepatitis B virus-related hepatocarcinogenesis in HepG2 cell lines.
    Shi Y; Wang J; Wang Y; Wang A; Guo H; Wei F; Mehta SR; Espitia S; Smith DM; Liu L; Zhang Y; Chen D
    Cancer Lett; 2016 Feb; 371(2):285-91. PubMed ID: 26706415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53.
    Shiota G; Oyama K; Udagawa A; Tanaka K; Nomi T; Kitamura A; Tsutsumi A; Noguchi N; Takano Y; Yashima K; Kishimoto Y; Suou T; Kawasaki H
    J Med Virol; 2000 Oct; 62(2):151-8. PubMed ID: 11002243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B Virus-Upregulated LNC-HUR1 Promotes Cell Proliferation and Tumorigenesis by Blocking p53 Activity.
    Liu N; Liu Q; Yang X; Zhang F; Li X; Ma Y; Guan F; Zhao X; Li Z; Zhang L; Ye X
    Hepatology; 2018 Dec; 68(6):2130-2144. PubMed ID: 29790592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein inhibits nucleotide excision repair.
    Jia L; Wang XW; Harris CC
    Int J Cancer; 1999 Mar; 80(6):875-9. PubMed ID: 10074921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1.
    Chen Y; Zhao ZX; Huang F; Yuan XW; Deng L; Tang D
    J Cell Physiol; 2019 Apr; 234(4):3555-3569. PubMed ID: 30565670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hepatitis B virus on p53 expression in hepatoma cell line SMMU-7721.
    Qu JH; Zhu MH; Lin J; Ni CR; Li FM; Zhu Z; Yu GZ
    World J Gastroenterol; 2005 Oct; 11(39):6212-5. PubMed ID: 16273653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yin-Yang 1 and HBx protein activate HBV transcription by mediating the spatial interaction of cccDNA minichromosome with cellular chromosome 19p13.11.
    Shen C; Feng X; Mao T; Yang D; Zou J; Zao X; Deng Q; Chen X; Lu F
    Emerg Microbes Infect; 2020 Dec; 9(1):2455-2464. PubMed ID: 33084547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX.
    Doitsh G; Shaul Y
    Oncogene; 1999 Dec; 18(52):7506-13. PubMed ID: 10602509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of three core genes in p53 signaling pathway in hepatitis B virus-related hepatocellular carcinoma.
    Yu M; Xu W; Jie Y; Pang J; Huang S; Cao J; Gong J; Li X; Chong Y
    World J Surg Oncol; 2021 Mar; 19(1):66. PubMed ID: 33685467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
    Cao P; Yang A; Wang R; Xia X; Zhai Y; Li Y; Yang F; Cui Y; Xie W; Liu Y; Liu T; Jia W; Jiang Z; Li Z; Han Y; Gao C; Song Q; Xie B; Zhang L; Zhang H; Zhang J; Shen X; Yuan Y; Yu F; Wang Y; Xu J; Ma Y; Mo Z; Yu W; He F; Zhou G
    Gastroenterology; 2018 Aug; 155(2):542-556. PubMed ID: 29702115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.